59 studies found for:    Carcinoembryonic antigen
Show Display Options
Rank Status Study
21 Completed Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: yttrium Y 90 monoclonal antibody MN-14
22 Recruiting A Study of RO6895882 in Patients With Advanced and/or Metastatic Solid Tumors
Condition: Neoplasms
Intervention: Drug: RO6895882
23 Completed Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: CEA peptide 1-6D
24 Withdrawn Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma
Condition: Colorectal Carcinoma
Interventions: Other: Cetuximab and Radiation Therapy;   Procedure: Surgery and Radiation Therapy
25 Unknown  Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
Condition: Circulating Tumor Cells
26 Completed Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Condition: Colorectal Cancer
Interventions: Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
27 Completed Immune Response in Peripheral Blood of Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis
28 Unknown  Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
29 Active, not recruiting Tecemotide (L-BLP25) in Rectal Cancer
Condition: Rectal Cancer
Interventions: Other: Chemoradiation Therapy;   Drug: Cyclophosphamide (CPA);   Other: Biological: Tecemotide (L-BLP25)
30 Recruiting A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
Condition: Gastrointestinal Adenocarcinomas
Intervention: Drug: MEDI-565
31 Recruiting Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Other: Blood sampling
32 Recruiting PET-CT and Circulating Tumor Cells in Colorectal Cancer
Conditions: Colorectal Cancer;   Metastasis
Intervention: Drug: Chemotherapy
33 Unknown  Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: radiation therapy;   Drug: capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
34 Completed Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: denileukin diftitox;   Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine;   Biological: therapeutic autologous dendritic cells
35 Completed Enzastaurin for Patients With Metastatic Colorectal Cancer
Condition: Colonic Neoplasms
Intervention: Drug: Enzastaurin HCl
36 Completed Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Biological: MelCancerVac
37 Recruiting Evaluation of SAR408701 in Patients With Advanced Solid Tumors
Condition: Neoplasm Malignant
Intervention: Drug: SAR408701
38 Completed Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: cryosurgery;   Procedure: radiofrequency ablation;   Procedure: therapeutic conventional surgery
39 Active, not recruiting Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia;   Recurrent Thyroid Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: sorafenib tosylate;   Other: pharmacological study;   Other: laboratory biomarker analysis
40 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results
Indicates status has not been verified in more than two years